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Significance: A 2018 retrospective analysis of Medicare beneficiaries identified
that*8.2 million people had wounds with or without infections. Medicare cost
estimates for acute and chronic wound treatments ranged from $28.1 billion to
$96.8 billion. Highest expenses were for surgical wounds followed by diabetic
foot ulcers, with a higher trend toward costs associated with outpatient wound
care compared with inpatient. Increasing costs of health care, an aging pop-
ulation, recognition of difficult-to-treat infection threats such as biofilms, and
the continued threat of diabetes and obesity worldwide make chronic wounds a
substantial clinical, social, and economic challenge.
Recent Advances: Chronic wounds are not a problem in an otherwise healthy
population. Underlying conditions ranging from malnutrition, to stress, to
metabolic syndrome, predispose patients to chronic, nonhealing wounds. From
an economic point of view, the annual wound care products market is expected
to reach $15–22 billion by 2024. The National Institutes of Health’s (NIH)
Research Portfolio Online Reporting Tool (RePORT) now lists wounds as a
category.
Future Directions: A continued rise in the economic, clinical, and social impact
of wounds warrants a more structured approach and proportionate investment
in wound care, education, and related research.
Keywords: human wound burden, wound care economics, military wound
care, wound care training and education
INTRODUCTION
A 2009 review of the state of hu-
man skinwounds and the threat they
present to public health and the
health care economy provided an
overview of the far-reaching impact
of chronic wounds. There is a need for
allocation of resources to understand
the mechanistic basis of cutaneous
wound complications.1 The current
article is intended to provide an up-
date on the rising threat that chro-
nic wounds present to global health
and economy. A recent retrospective
analysis of the Medicare 5% dataset
for 2014 analyzed all wound cate-
gories, including acute and chronic
wounds, and identified that about 8.2
million Medicare beneficiaries had at
least one type of wound or related
infection.2 Medicare cost projections
for all wounds ranged from $28.1
billion to $96.8 billion, including costs
for infection management, among
which surgical wounds and diabetic
ulcers were the most expensive to
treat.2 Furthermore, outpatient costs
($9.9–$35.8 billion) were higher than
inpatient costs ($5.0–$24.3 billion),
possibly because of an increase in
outpatient wound treatments that are
currently provided.2
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CHRONIC WOUNDS
Wounds that have not progressed through the
normal process of healing and are open for more
than a month are classified as chronic wounds.3
There are varying etiologies of chronic wounds, all
of which burden the health care system. Patients
suffering from diabetes and obesity are at a high
risk of developing chronic wounds. A vast majority
of the people who have a prolonged open wound
usually also have other major health conditions.
The simultaneous presence of a combination of
chronic diseases is called a comorbidity. Chronic
wounds are often complicated by comorbidities,
making it difficult to track chronic wounds as a
disease in itself.3 As such, research funding di-
rectly addressing the study of chronic wounds is
disproportionately low compared with the overall
impact of chronic wounds as a health care prob-
lem.4,5 National Institutes of Health has recently
set up the first consortium of its kind, a national
Diabetic Foot Consortium (NIDDK; FOA: DK17-
014; NOT-DK-18-017), aimed at bringing experts
across the United States together to improve the
care of diabetic foot ulcers (DFUs).
Chronic wounds are mostly seen in the elderly
population.2,6 In the United States, 3% of the pop-
ulation >65 years of age have openwounds. By 2020,
the US government estimates that the elderly pop-
ulation will be over 55 million, suggesting that
chronic wounds will continue to be an increasingly
persistent problem in this population.7 Overall, in
the United States *2% of the total population are
estimated to be affected by chronic wounds.8 The
impact of chronic wounds is also adverse worldwide.
For example, a 2016 report from Wales estimated a
6% prevalence of chronic wounds with a 5.5% cost to
the National Health Service (NHS).9
In the world’s largest wound-dressing markets,
United States and Europe, there is a significant
demand for wound care products. Globally, the an-
nual cost for wound care was an average of $2.8
billion in 2014. It is projected to rise up to $3.5 billion
in 2021.10 The 2018market research report predicts
that the global wound-closure products market will
exceed $15 billion by 2022.11 The advanced wound
care market targeting surgical wounds and chronic
ulcers is expected to exceed $22 billion by 2024,
driven by technological advancement, rising inci-
dences of chronic wounds, increasing government
support, and a rising geriatric population.12
PRESSURE ULCERS
Pressure, or pressure in combination with shear
and/or friction, promotes the development of lo-
calized ulcers called pressure ulcers (PUs). PU care
is expensive and costs more than $11 billion an-
nually in the United States per the Agency for
Healthcare Research and Quality (AHRQ) statis-
tics.13 Cost of individual patient care ranges from
$20,900 to $151,700 per PU.13 Apart from hospital
costs, additional charges for food, transportation, and
maintenance is *$43,180 per year.13 Elderly pa-
tients; patients with stroke, diabetes, dementia; and
thosewith impaired/limitedmobility or sensation are
extremely vulnerable to PU. Prolonged sedentary
stays in the intensive care unit can also drive PU
development in otherwise healthy patients.
The incidence of PU increases with age and is
promoted by a lack of skin perfusion, moisture, and
nutrition.14 In theUnited States around 2.5million
people develop PUs annually.13 They are usually
preventable, but they can be lethal if proper, timely
care is not received.15–19 The global market for PU
care products is expected to reach $4.5 billion by
2024.20 Factors that spur this increase include the
aging population and associated mobility and
neurological disorders.20
DIABETES
The Centers for Disease Control and Prevention
(CDC) recently released a study that indicated that
more than 100 million adults are living with dia-
betes or prediabetes in the United States.21 As of
2015, 30.3 million Americans (9.4% of the US pop-
ulation) live with diabetes; besides, 84.1 million
have prediabetes, which if left untreated often
leads to type 2 diabetes (T2D) within 5 years.21
Diabetes prevalence has been found to increase
with age. Four percent of adults aged 18–44, 17% of
adults aged 45–64 years, and 25% of those aged ‡65
years have diabetes.21
Worldwide, there are an estimated 400 million
people living with diabetes.22 In reference to the
statistical studies by the World Health Organiza-
tion (WHO) in 91 countries globally, it was identi-
fied that a tiny island country in Micronesia,
Nauru, had the highest prevalence rate of 30.9% in
2010.23 This was projected to rise to 33.4% by the
year 2030.23 United Arab Emirates was next in line
with 18.7% prevalence in 2010, and a projected
increase to 21.4% in 2030.23 The age of diabetes
onset in developing countries is 45–64.24 By 2030 it
is predicted that developing countries will have
more people (>65 years of age) with diabetes (82
million) than developed countries (48 million).25
The prevalence of foot ulcers (FUs) is high in the
diabetic population and has a neuropathic ori-
gin.26,27 The annual prevalence of FUs is estimated
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to be 4–10%, and the risk of development of these
ulcers in diabetics is estimated to be anywhere
from 15% to 25%.28 Themanagement of DFUs costs
$9–$13 billion in the United States.26
By 2026, the T2D market is expected to rise
from $28.6 billion to an estimated $64 billion. A
compound annual growth of 8.4% is expected in
the United States, France, Germany, Italy, Spain,
the United Kingdom, and Japan.29 In the United
States, the demand for insulin pumps is expected to
rise to a $3.8 billion business by 2022, driven by the
increasing number of people with diabetes, as well
as technological advances in treatment.30
FOOT ULCERS
An open sore on the foot is called a FU. It may be
shallow, confined only to the surface of the skin.
Deep FUs can involve full thickness of the skin,
muscle, tendons, and bones. FUs are common in
people with diabetes and individuals with compro-
mised blood circulation.31 Despite advanced health
care and pharmacotherapy techniques that are
widely available, the prevalence of FU has not
changed in the past two decades.32 Fourteen per-
cent to 24% suffer from amputation.33 Neuro-
ischemic ulcers are particularly associated with
limb amputations.27
Recently, a systematic review and meta-analysis
of the global epidemiology of FUs was performed
using PubMed, EMBASE, ISI Web of Science, and
Cochrane database searches. This was the largest
analysis of its kind, including >800,000 subjects
from 33 countries. The global DFU prevalence was
found to be 6.3%. The lower prevalence of DFU in
Europe (5.1%) compared with North America
(13.0%) presents a striking difference. Out of 33
countries, Belgium had the highest prevalence with
16.6% and Australia the lowest with 1.5%. Men ap-
peared to be more prone to FUs than women (4.5%
vs. 3.5%). Furthermore, FUs were seen more often
in patients with T2D compared with type 1 diabetes
(6.4% vs. 5.5%).34,35 In general, patients with FUs
were older, had a lower body mass index (BMI),
longer diabetes duration, higher hypertension rates,
higher incidence of diabetic retinopathy, and a
smoking history, compared with those without FUs.
The global DFU market expects a positive 6.6%
compound annual growth rate between 2016 and
2024. At this pace, the market’s valuation may
reach $4.9 billion by the end of 2024. Regionally,
the United States dominated the global market in
2016 with an estimated share of 38.1%. It is ex-
pected to remain dominant through the forecast
period (2024).36
VENOUS ULCERS
A vast majority (70%) of lower-extremity ulcers
are caused by chronic venous insufficiency.37 In the
United States and Europe, people >65 years of age
are vulnerable to venous ulcers.38 The prevalence of
venous ulcers is 1% of the population globally among
those aged 18–64.39 In the United States, 10–35% of
the population suffer from some kind of chronic ve-
nous issues with 4% (>65 age group) of the cases
having active ulcers.40 In the United States and the
United Kingdom, venous leg ulcers cost around $2.5
billion and £300–600 million, respectively.41 The
annual expenditure to treat a venous ulcer is esti-
mated at $10,563.42 For chronic, nonhealing venous
ulcers, the treatment expenditure is estimated to be
*$34,000 or higher.42 Chronic venous ulcers bur-
den economic productivity by resulting in the loss of
4.6 million work-days per year.43
OVERWEIGHT AND OBESITY
According to a recently updated report from the
WHO, worldwide obesity has nearly tripled be-
tween 1975 and 2016.44 Excessive accumulation of
fat complicates numerous aspects of vital functions
within the body, causing illness and posing a risk
for an increase in additional health complications.
For adults, WHO defines overweight as a BMI ‡25.
Obesity is defined as a BMI ‡30.44 Estimates from
2016 indicated that 39% of adults (1.9 billion; ‡18
years) worldwide were overweight, and 13% (>650
million) were obese.44 Among these, women were
more prone to overweight or obesity than men. The
threat of obesity is not a menace only for adults.
Globally, 340 million children and adolescents,
aged 5–19, were overweight or obese in 2016.44 In
children <5 years, 41 million were either over-
weight or obese.44
Overweight and obese are at a high risk for
noncommunicable diseases44–46 such as:
 Cardiovascular diseases (primarily heart
disease and stroke)
 Diabetes and associated chronic wounds
 Musculoskeletal disorders
 Some cancers (including endometrial, breast,
ovarian, prostate, liver, etc).
Childhood obesity47,48 is associated with a pre-
disposition to breathing difficulties, increased ten-
dency toward fractures, hypertension, increased
risk of cardiovascular disease, insulin resistance,
and psychosocial impacts.49,50
In adults, the association between obesity and
multiple complications such as impaired or totally
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failed cutaneous wound healing, particularly fol-
lowing surgery, has been identified by various
groups.51–60 Being overweight or obese signifi-
cantly increases the likelihood of infection-related
complications comparedwith those within a healthy
weight range.61 There are many factors that con-
tribute to the chronicity of infection in obese people.
Decreased vascularization of the adipose tissue is a
major cause for increased infection in obese pa-
tients.53 Such poor perfusion limits the supply of
host immune cells that represent key components of
host defenses against infection.53,62–64
In obese individuals, intentional weight loss was
associated with *15–18% reduction in all-cause
mortality.65,66 Intragastric balloons (IGBs) are the
leading treatment options for obesity and associ-
ated diseases. The growing acceptance of mini-
mally invasive surgical methods for IGB insertion
is expected to fuel the rising use of this methodol-
ogy. The IGB market value is expected to exceed
$270 million by 2024.67
PERILS OF CHRONIC WOUNDS
Access and delivery of wound care are both sig-
nificant problems that challenge patients suffering
from chronic wounds. Lack of access to specialized
wound care has resulted in amputations and loss
of work productivity.8,68–70 In the United States,
chronic ulcers are conservatively estimated to cost
the health care system $28 billion each year as a
primary diagnosis and up to $31.7 billion as a sec-
ondary diagnosis.71 According to the American
Diabetes Association (ADA), over 9–12 million
Americans suffer from chronic ulcers.72 The mor-
tality rate for leg ulcers after the first amputation
has dramatically doubled from 20% to 50% in the
first 3 years to 70% after 5 years.72 There is a pro-
found psychological impact on the patients suffer-
ing from chronic wounds, such as loneliness,
separation from an active social life, and depres-
sion. These psychosocial stressors further worsen
healing outcomes.73,74
ACUTE WOUNDS
Disruptions in the integrity of the skin that
heals uneventfully with time are considered acute
wounds.3 Surgical and traumatic wounds, abra-
sions, or superficial burns are generally considered
acute wounds.3 Every time the integrity of the cu-
taneous barrier is compromised, a wound is cre-
ated. Wound infections complicate recovery from
surgery and significantly increase the cost of
wound care postsurgery. The development of novel
and practical concepts to prevent and treat these
wound infections are key to effective wound man-
agement.
In 2014, acute wounds resulted in 17.2 million
hospital visits, including ambulatory/outpatient and
inpatient surgical visits.75 The majority (57.8%) of
these visits occurred in hospital-owned outpatient
settings, while 42.2% were inpatient.75 Outpatient
visits were primarily (48.6%) covered by private in-
surers, while Medicare primarily (43.4%) covered
inpatient surgical stays.75
Hospital discharge data derived from the
Healthcare Cost and Utilization Project (HCUP)
from burn-related hospital inpatient stays and
emergency department visits identify that al-
though there have been significant improvements
in treatment options for burn injuries, the fre-
quency and associated costs of these injuries re-
main high.76 Almost half million patients were
treated for burns in 2011. Costs estimates show
that*$1.5 billion was spent in burn injury care in
2010. An additional $5 billion in costs was associ-
ated with lost work-hours. The length of inpatient
stay of burn patients was estimated to be twice that
of nonburn-related stays.76
Surgical site infections (SSI) represent a major
concern in overall health care in the United States
and worldwide.77–79 It is the second leading cause
of hospital-acquired infections costing $3.5–$10
billion per year.80,81 Despite all efforts, SSI con-
tributes to mortality in 75% of cases.82,83
Emergency wound care for acute wounds has
relevance in combat settings and preparedness
against natural disasters, terrorist attacks, and
other such events that result in acute injuries.
Survivors of bombings are primarily impacted at
the soft tissue and musculoskeletal system level.84
Amputations are the unfortunate end result of the
most extreme of these injuries and reported to oc-
cur in 1–3% of blast victims.84,85 Acute wound care
accompanied by associated infections may highly
impact occupational health.
INFECTION
Bacteria rapidly colonize in open skin wounds
after burn injury86–90 or surgical incisions.51,91–96
Microorganisms colonizing these wounds are typi-
cally the patient’s normal flora97–101 or may be
transferred via contact with contaminated water,
fomites, or the soiled hands of health care work-
ers.102–106 Gram-positive bacteria such as Staphy-
lococcus aureus, Enterococcus spp., and Gram-
negative organisms such as Pseudomonas aerugi-
nosa, Acinetobacter spp., fungi like Candida spp.,
Aspergillus spp., are all among a list of common
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pathogens that can cause acute wound infections,
and several of them are resistant to antibiotics.107
An important factor in the failure of a sore to
heal is the presence of polymicrobial consortia,
living cooperatively in highly organized biofilms.
The biofilm shields the pathogenic microbes from
antimicrobial therapy and the patient’s immune
response. Biofilm infections have been linked to
wound chronicity.89,90,108–112 Recent studies reveal
that biofilm infection may directly hinder wound
closure or cause defective wound closure where the
wound site appears closed but the repaired skin
lacks barrier function.87,89,90,112 Such observation
calls for a revision of the current wound care end-
point. Covering of a wound and a lack of discharge
may not be adequate criteria to declare a wound
closed. It is important to add that the repaired skin
must have physiological functionality. Thus, cov-
ering of the wound, a lack of discharge, and resto-
ration of barrier function should be considered as
criteria for wound closure in patients. It is sus-
pected that wounds that appear closed, but are
deficient in barrier function, lend themselves to
wound recurrence. Patient-based studies (NCT
02577120) are currently in progress to test this
hypothesis.
MALNUTRITION
The process of wound healing, involving de novo
tissue generation, is a metabolic and calorie-
demanding process. From a microenvironment
standpoint, energy needs to be generated to enable
cellular repair mechanisms, chemotactic responses
(growth factors and cytokine response), cell motil-
ity, division, and differentiation.113,114 At a macro-
environment scale, patientswithnonhealingwounds
often suffer from nutritional deficiencies.115 Those
with, compared with those without, nutritional def-
icits are more likely to develop chronic wounds that
are slower to heal.116–118
STRESS
Another key determinant relating to wound
outcomes is psychosocial stress.52,73,119–122 Stress
impairs cellular immunity, compromising wound
healing. The discipline of psychoneuroimmunology
(PNI) is of direct relevance to wound healing out-
comes.123,124 PNI provides a key insight into how
the immune system bi-directionally communicates
with the central nervous and endocrine systems
and how these communications impact health
outcomes.123,124 Stress-induced immune dysregu-
lation results in impaired wound healing.123,125,126
SCAR AND FIBROSIS
Scars and associated functional as well as aes-
thetic concerns represent a huge burden on health
care.127 Burn wounds usually leave hypertrophic
scars after they have healed. In particular, the face
is highly susceptible to excessive scarring, causing
functional deficits. Some of the critical facial char-
acteristics following thermal injury of the face in-
clude ectropion (epithelial-ocular junction), eversion
of the lip (epithelial-oral junction), and excessive
skin contracture. Deficits such as oral incompetence
are common. Such disorders cause social, emotional,
and psychological burdens. Patients with such facial
disfigurations showed symptoms of depression,
anxiety, and hostility, compared with a matched
normal control group, for a period of up to 1 year post
trauma.128 Other than the face, scarring is a sub-
stantial health care problem today. The global skin
scar therapymarket is expected to reach around $35
billion by 2023.129
PHYSICIAN EDUCATION
Comprehensive education is critical for the de-
velopment of wound care management as a disci-
pline in mainstream medicine.130 Formal wound
care education in US medical schools is often weak
at best. Of 55 schools surveyed throughout the
United States, only seven offered a formal wound
healing elective.131 Typically, education and train-
ing in wound care for the medical students within
the United States do not exceed >9.2h in the 4-year
curriculum.132 To help address this gap in medical
training, the American College of Wound Healing
and Tissue Repair was founded to help train phy-
sicians specialize in wound care. This institution is
currently working toward accreditation by the
AmericanBoard ofMedical Specialties and hopes to
achieve this by 2022.130
In Europe, wound care education lacks consensus
in relation to theminimumeducation needed to be an
expert in wound care.133 Various diploma and certif-
icate programs are available inFrance, England, and
Wales. The European Wound Management Associa-
tion (EWMA) is working toward establishing a core
standard for acceptable wound management educa-
tion.133 In Denmark, however, a 2-year additional
educational experience following basic specialty
training has been developed for medical doctors.133
NURSING EDUCATION, PHYSICAL THERAPY,
AND OSTOMY
Traditionally, wound healing has been under the
aegis of basic nursing practices,134 such as wound
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covering management, therapeutic nutrition, and
mobility and psychosocial support. Nurses play a
crucial role in handling andmanaging acutewounds
and chronic wounds such as PUs, bedsores, FUs,
and venous ulcers. The Wound Ostomy and Con-
tinence Nurses (WOCN) Society is the oldest wound
care society that has board-certified over 6,000
nurses worldwide.134 They are considered the gold
standard for certification inwoundnursing, and this
process requires completion of a rigorous curriculum
followed by stringent recertification processes.134 In
2010, the Organization of Wound Care Nurses
(OWCN) was established.135 It provides the foun-
dation and free-of-cost training for all the licensed
nurses who are practicing in different care settings.
Wound care and ostomy education programs for
nurses are increasingly becoming available in an
effort to improve nursing service quality.136
Appropriate professional use of multiple wound
care disciplines may markedly impact wound
care.137–139 Physical therapy represents one such
major discipline. Trained physical therapists may
employ numerous treatment regimens, such as
wound debridement, modalities, edema manage-
ment, positioning, orthotic use, and mobility im-
provement. Occupational therapists may provide
edemamanagement,wounddebridement, position-
ing, toileting programs, self-feeding, and wheel-
chair management as relevant to the need of the
patient. Addressing supportive interventions such
as physical and occupational therapy and nutrition
management are likely to promote the rate of
wound healing, thereby lowering the overall costs
of wound care. After all, the longer a patient’s
healing time, the higher the cost to the facility.
Wound, ostomy, and continence nurses, in addi-
tion to being educated and trained to provide acute
and rehabilitative care, represent an important
component of the wound care ecosystem.140–142
Ostomies, stomas, acute and chronic wounds, and
urinary and fecal incontinence often present severe
physical challenges to wound patients. These lead
to emotional and social issues that may be ad-
dressed by properly trained allied medical profes-
sionals. Limitations in well-structured education of
wound care providers may be viewed as a signifi-
cant barrier to uniform evidence-based wound care
throughout the country.
PATIENT EDUCATION
Literature addressing patient-centered wound
care has mostly focused on quality of life (QoL),
pain, adherence, and coping. A key concern from
the patients’ perspective is improved provider rec-
ognition of patients’ concerns in treatment plan-
ning and request for personalized approaches.
The evolution to shared wound care decision
making is what patients are seeking.143,144 Enga-
ging patients’ awareness and involvement in
wound management is key to ensuring successful
healing outcomes.145
COMBAT WOUND CARE
In the military and related defense services,
wounds and trauma are a common problem. In
2017, the National Academies of Science, En-
gineering, andMedicine reported a new vision for a
national trauma care systemwith the ultimate aim
of ‘‘zero’’ preventable deaths after injury to benefit
those in combat.146 This vision is based on studies
conducted between 2001 and 2011,which identified
that *75% of combat deaths were caused by ex-
plosions and lack of timely and appropriate care
before the patient reached a medical treatment
facility.146
The Department of Defense (DoD) and the US
Department of Veterans Affairs (VA) are the two
federal government institutions involved in pro-
viding health care to the 3.9 million US military
members who served in Operation Enduring
Freedom and Operation Iraqi Freedom (OEF/
OIF), the 17 million veterans from prior periods,
and the 1.3 million active personnel and their
families.147
The DoD covers active service members, and the
VA provides medical support to eligible retirees.
The TRICARE for Life program is a wraparound
plan meant to supplement Medicare coverage of
military retirees and to pay for military hospitals
and health care workers.148 The VA estimates
that around 25% of military veterans have dia-
betes149,150 (compared with 9% of the civilian
adult population). The economic burden of lower
limb amputations in diabetic veterans was $206
million.151
The Combat Casualty Care Research Program is
a collaborative, multidisciplinary partnership that
utilizes clinical and translational research to pro-
vide state-of-the-art wound care.152 With an effort
to maximize restoration of function and QoL in
service members with combat-related extremity
trauma, the VA and DoD have increased their re-
search and clinical care efforts with a focus on re-
generative medicine.153
CLOSING REMARKS
Based on estimates originating from independent
sources, it is clear that themagnitude of wounds as
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a health care problem is sharply rising. Resources
allocated to the education, care, and research of
wounds continues to be disproportionately low and
deserves strategic attention. A key challenge in all
of these three domains—education, care, and re-
search—is the ability to recruit interdisciplinary
talent that would work together cohesively as one
team.
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